Trials / Completed
CompletedNCT03153267
Duration of Doxycycline Treatment in EM Patients
Duration of Doxycycline Treatment in Patients With Erythema Migrans (EM). A Randomized Clinical Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 300 (actual)
- Sponsor
- University Medical Centre Ljubljana · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the efficacy of 7-day versus 14-day doxycycline treatment in patients with erythema migrans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline 100 MG Oral Tablet bid, 7 days | Patients will receive doxycycline for 7 days. |
| DRUG | Doxycycline 100 MG Oral Tablet bid, 14 days | Patients will receive doxycycline for 14 days. |
| DRUG | Controls without a history of lyme disease. | No intervention. |
Timeline
- Start date
- 2017-06-01
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
- First posted
- 2017-05-15
- Last updated
- 2020-03-25
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03153267. Inclusion in this directory is not an endorsement.